Skip to content

Evaluating Laser Otoscope for Middle Ear Effusion Detection

Evaluation of an Investigational Laser Otoscope for Detection of Middle Ear Effusion in Pediatric Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07454512
Enrollment
150
Registered
2026-03-06
Start date
2026-03-01
Completion date
2026-09-01
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Middle Ear Effusion, Otitis Media

Brief summary

The goal of this cross-sectional diagnostic accuracy investigational study is to learn about the usefulness of laser otoscopy in screening for middle ear fluid. The main questions it aims to answer are: -Accuracy and usability of doctors using laser otoscopes Participants already having ear tubes placed will have an examination with a laser otoscope and white light otoscope in order to determine and compare the device's diagnostic assistance. Tympanostomy findings will be used as the ground truth.

Interventions

DEVICELaser otoscope examination

Patients will have short videos taken of their tympanic membranes under white light and laser illumination.

Sponsors

MSTATT LLC
Lead SponsorINDUSTRY
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
The Cleveland Clinic
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled to undergo unilateral or bilateral myringotomy with ear tube placement * Between the ages of 6 months to 18 years at the time of consent * Able to provide assent as judged by the investigator or delegated personnel, and their parent(s) or legal guardian(s) has signed the current Institutional Review Board (IRB) approved informed consent form along with the HIPAA Authorization for the use and release of Private Health Information (PHI) or applicable privacy protection

Exclusion criteria

* History of prior ear tube placement * Anatomical abnormalities of the tympanic membrane or ear canal * Presence of excessive cerumen that cannot be removed pre-exam and may interfere with study procedures * Any of the following deformities of the external ear and tympanic membrane: congenital canal stenosis or atresia, severe canal tortuosity or curvature which prevents visualizing the tympanic membrane fully with an otoscope, canal wall exostoses or osteomas, markedly thickened or opaque tympanic membranes such as caused by chronic myringitis, or scarring or fibrosis of the tympanic membrane, tympanosclerosis or other heavy calcification of the tympanic membrane, tympanic membrane perforations, and grafted tympanic membranes.

Design outcomes

Primary

MeasureTime frameDescription
Clinician diagnostic accuracy using laser otoscope to assess middle ear effusion presenceFrom enrollment to data collection at tympanostomy typically at 2-3 weeksThe primary endpoint is the accuracy, PPV, and NPV of the MEEscope in detecting MEE validated by myringotomy findings. These values will be compared to the standard white-light otoscopy findings in the same patients to demonstrate the relative accuracy of the experimental illumination vs white light illumination in detection of MEE.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026